120 related articles for article (PubMed ID: 3001289)
1. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
Fryklund J; Wallmark B
J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
Nandi J; King RL; Kaplan DS; Levine RA
J Pharmacol Exp Ther; 1990 Mar; 252(3):1102-7. PubMed ID: 2156990
[TBL] [Abstract][Full Text] [Related]
4. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of HOE 731 in isolated rabbit gastric glands.
Herling AW; Becht M; Lang HJ; Scheunemann KH; Weidmann K; Scholl T; Rippel R
Biochem Pharmacol; 1990 Oct; 40(8):1809-14. PubMed ID: 2173590
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
Nagaya H; Satoh H; Kubo K; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):799-805. PubMed ID: 2537417
[TBL] [Abstract][Full Text] [Related]
8. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
Wallmark B; Brändström A; Larsson H
Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
[TBL] [Abstract][Full Text] [Related]
9. Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole.
Beil W; Staar U; Sewing KF
Eur J Pharmacol; 1990 Oct; 187(3):455-67. PubMed ID: 1963594
[TBL] [Abstract][Full Text] [Related]
10. A newly synthesized pyridine derivative, (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine hydrochloride (AU-1421), as a reversible gastric proton pump inhibitor.
Hioki Y; Takada J; Hidaka Y; Takeshita H; Hosoi M; Yano M
Arch Int Pharmacodyn Ther; 1990; 305():32-44. PubMed ID: 2173509
[TBL] [Abstract][Full Text] [Related]
11. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.
Fryklund J; Gedda K; Scott D; Sachs G; Wallmark B
Am J Physiol; 1990 May; 258(5 Pt 1):G719-27. PubMed ID: 2159239
[TBL] [Abstract][Full Text] [Related]
12. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
[TBL] [Abstract][Full Text] [Related]
13. BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions.
Kromer W; Postius S; Riedel R; Simon WA; Hanauer G; Brand U; Gönne S; Parsons ME
J Pharmacol Exp Ther; 1990 Jul; 254(1):129-35. PubMed ID: 2164086
[TBL] [Abstract][Full Text] [Related]
14. Function and structure of parietal cells after H+-K+-ATPase blockade.
Fryklund J; Helander HF; Elander B; Wallmark B
Am J Physiol; 1988 Mar; 254(3 Pt 1):G399-407. PubMed ID: 2831735
[TBL] [Abstract][Full Text] [Related]
15. Specific labelling of gastric H+,K+-ATPase by omeprazole.
Fryklund J; Gedda K; Wallmark B
Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
Im WB; Sih JC; Blakeman DP; McGrath JP
J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.
Scott CK; Sundell E; Castrovilly L
Biochem Pharmacol; 1987 Jan; 36(1):97-104. PubMed ID: 3026407
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibition--the ultimate control of acid secretion?
Zdon MJ; Ballantyne GH; Schafer DE; Tyshkov M; Cambria RP; Modlin IM
J Surg Res; 1986 Apr; 40(4):353-61. PubMed ID: 2422442
[TBL] [Abstract][Full Text] [Related]
19. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
[TBL] [Abstract][Full Text] [Related]
20. Effects of verapamil on gastric acid secretion in vitro and in vivo.
Herling AW; Ljungström M
Eur J Pharmacol; 1988 Nov; 156(3):341-50. PubMed ID: 2850932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
